Why Compare Wegovy and Mounjaro Through Private Prescription?
Private Prescription Advantages When Comparing Wegovy and Mounjaro
When weighing Wegovy compared to Mounjaro through the NHS, patients typically face GP referrals to specialist weight management services with waiting times exceeding six months. Private prescription eliminates these barriers, allowing direct access to both treatments through clinical assessment. EverydayMeds' prescribers can evaluate your medical history, current medications, and treatment goals to help determine whether Wegovy's GLP-1 mechanism or Mounjaro's dual GIP+GLP-1 approach aligns better with your circumstances.
The private route also provides flexibility in treatment timing and ongoing support that NHS services often cannot accommodate due to capacity constraints. Both Wegovy and Mounjaro require careful dose escalation over 16-20 weeks, and private prescription ensures consistent supply without appointment delays. Our prescribers understand the nuanced differences between these treatments and can adjust recommendations based on your response, tolerability, and practical considerations like travel requirements.
Transparent Pricing for Wegovy Compared to Mounjaro
Wegovy pricing starts at £79.99 for the 0.25mg starter pen, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25. Our Getting Started bundles provide dose progression convenience — the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99 for your first three months of treatment.
Mounjaro follows a different pricing structure due to its distinct dose escalation schedule and dual-agonist formulation. Both treatments represent significant private healthcare investments, but the ability to start immediately rather than waiting months for NHS specialist referral often justifies the cost for patients frustrated with delays. EverydayMeds provides transparent pricing without hidden consultation fees — the medication cost is your only expense.
Clinical Evidence Comparing Wegovy and Mounjaro Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones to reduce appetite and promote satiety. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% over 68 weeks (Wilding et al., NEJM, 2021). The treatment works primarily through brain appetite centres and gastric emptying regulation.
Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors — a dual mechanism that may offer different therapeutic benefits. Both treatments require prescription-only medicine status and clinical monitoring, but their distinct mechanisms mean individual responses can vary significantly. Your prescriber can discuss which mechanism aligns better with your medical history and treatment objectives.
How Wegovy Works in Your Weight Management Journey
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of natural hormones that signal fullness after eating. The medication works on appetite centres in the brain to reduce food cravings and increase feelings of satiety after smaller portions. This mechanism can help support portion control and reduce between-meal snacking when combined with structured dietary changes. The weekly injection maintains consistent medication levels, providing sustained appetite regulation throughout your treatment period. Clinical studies suggest this approach may help patients maintain dietary modifications that would otherwise prove difficult through willpower alone.
Streamlined Ordering Process for Both Treatments
EverydayMeds' private prescription process begins with a 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Our prescribers review applications within three working days (24-hour express review available), evaluating suitability for either Wegovy or Mounjaro based on clinical guidelines. Once approved, your medication ships via next-day cold-chain delivery to maintain temperature integrity throughout transport. The FlexTouch pen system arrives with comprehensive injection guidance and dose escalation schedules tailored to your chosen treatment. Our pharmacy team remains available for ongoing support throughout your dose escalation journey.
Storage and Practical Considerations
Both Wegovy and Mounjaro require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability versus Mounjaro's 21-day limit. This storage advantage makes Wegovy more suitable for frequent travellers or those without reliable refrigeration access. The FlexTouch pen delivery system provides consistent dosing with pre-filled cartridges that eliminate measurement errors. Each pen contains four weekly doses, requiring monthly prescription renewals during dose escalation phases. Both treatments follow mandatory escalation schedules that cannot be accelerated, requiring patience and consistent administration timing.
Personalised Treatment Selection Through Private Prescription
When comparing Wegovy and Mounjaro through private prescription, individual factors often determine optimal choice rather than general superiority claims. Patients with diabetes history may have different considerations than those focused purely on weight management. Travel requirements, injection tolerance, and previous GLP-1 experience all influence treatment selection in ways NHS standardised pathways cannot accommodate.
EverydayMeds' prescribers evaluate these nuanced factors during clinical assessment, providing personalised recommendations rather than one-size-fits-all approaches. Both treatments are available through our service, ensuring clinical choice rather than supply-driven decisions. This flexibility represents a key advantage of private prescription when weighing Wegovy compared to Mounjaro for your specific circumstances.
Start Your Treatment Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds' private prescription service, with clinical assessment starting your journey toward supervised weight management. New customers apply code FIRST40 at checkout for optimal pricing, whilst returning patients use DOSE25 for continued value. Our GPhC-registered pharmacy (#9012878) ensures authentic medication supply with full regulatory compliance and clinical oversight. The 3-minute assessment opens door to prescriber consultation within days rather than months. Begin your comparison of Wegovy and Mounjaro today through our streamlined private prescription pathway.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
